Here you will find information about GSK’s medicines and vaccines
Important notice: this site is intended for UK healthcare professionals. By entering this site, you are confirming that you are a UK healthcare professional. This site may contain promotional information.
This site is intended for members of the UK public, patients and their carers.
M.C. Last updated: March 2018. UK/COM/0106/15(2)
Relvar Ellipta was developed in collaboration with INNOVIVA.
Relvar Ellipta was developed in collaboration with INNOVIVA. ITT, intent-to-treat; RCT, randomised controlled trial
Relvar is an ICS/LABA licensed in Asthma which could help your patients with asthma stand up to a 24-hour world.1
In the Salford Lung Study, an open label, effectiveness RCT comparing Relvar with usual care in over 4,000 patients, the most commonly used ICS/LABAs in the ITT population were3:
January 2018 MAT Asthma prescribing of Fostair5 Low dose = 13.7% Mid dose = 44% High dose = 10.4% Not specified = 31.8%
ZINC CODE - UK/FFT/0038/18
Date of preparation: June 2018